Clinical Trials
26 results.
Copenhagen, Denmark (August 28, 2023) — A one-year, phase 2 clinical trial of Type 2 diabetes drug lixisenatide has reported positive early results, which indicate…
Grand Rapids, Mich. (March 13, 2023) — Cure Parkinson’s and Van Andel Institute (VAI) are delighted to announce that their co-funding agreement, which supports…
London, United Kingdom (Jan. 10, 2023) — Following promising results reported at Phase 2 in 2020, a large-scale Phase 3 clinical trial of ambroxol,…
GRAND RAPIDS, Mich. (Nov. 1, 2022) — A pair of cancer medications that act as a one-two punch against malignant cells demonstrated increased survival in…
LONDON (Sept. 21, 2020) — The Cure Parkinson’s Trust (CPT) and Van Andel Institute (VAI) are delighted to welcome a third strategic funding partner, The…
With a new decade comes a new world of possibility and innovation waiting to be unleashed in labs at Van Andel Institute and across the…
Institute serves as a connector that fosters discovery of potential new treatments Clinical trials can be a bastion of hope for people living with terminal…
May is Cancer Research Month, which raises awareness for the efforts underway to prevent, treat and, ultimately, cure cancer.
When it comes to…